| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| osimertinib mechanism of action animation | 0.04 | 0.5 | 353 | 61 | 41 |
| osimertinib | 1.07 | 0.6 | 5824 | 40 | 11 |
| mechanism | 1.4 | 0.5 | 2976 | 91 | 9 |
| of | 1.58 | 0.1 | 1820 | 58 | 2 |
| action | 1.26 | 1 | 620 | 12 | 6 |
| animation | 0.83 | 0.7 | 5513 | 87 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| osimertinib mechanism of action animation | 1.59 | 0.6 | 4398 | 61 |
| osimertinib mechanism of resistance | 0.16 | 0.1 | 1044 | 63 |
| osimertinib duration of action | 1.85 | 0.6 | 4680 | 44 |
| how does osimertinib work | 0.5 | 0.9 | 4539 | 19 |
| resistance mechanisms to osimertinib | 1.17 | 0.1 | 861 | 23 |
| osimertinib mecanismo de accion | 0.58 | 0.5 | 4445 | 12 |
| osimertinib time to response | 1.14 | 1 | 3184 | 42 |
| ziftomenib mechanism of action | 1.29 | 0.3 | 4705 | 47 |
| what is osimertinib used for | 1.98 | 0.8 | 7837 | 81 |
| osimertinib plasma protein binding | 1.37 | 0.7 | 2754 | 100 |
| osimertinib scheda tecnica aifa | 1.12 | 0.3 | 1100 | 63 |
| primary resistance to osimertinib | 1.77 | 0.3 | 6062 | 14 |
| osimertinib + savolitinib | 0.64 | 0.7 | 2786 | 47 |
| osimertinib summary basis of approval | 1.27 | 0.7 | 941 | 76 |
| osimertinib_1919 | 0.98 | 0.4 | 944 | 10 |
| is osimertinib an immunosuppressant | 0.89 | 0.1 | 9459 | 76 |
| is osimertinib a chemotherapy drug | 1.72 | 0.6 | 1103 | 26 |
| osimertinib potential side effect | 1.17 | 1 | 667 | 12 |
| is osimertinib a chemotherapy | 0.85 | 0.7 | 9662 | 62 |
